Evolus (EOLS) Competitors

Evolus (NASDAQ:EOLS) and Merus (NASDAQ:MRUS) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

Is EOLS or MRUS more profitable?

Evolus has a net margin of -22.33% compared to Merus' net margin of -680.61%. Merus' return on equity of -38.89% beat Evolus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolus	-22.33%	-847.60%	-22.15%
Merus	-680.61%	-38.89%	-31.16%

Do analysts recommend EOLS or MRUS?

Evolus presently has a consensus target price of $23.75, indicating a potential upside of 120.29%. Merus has a consensus target price of $85.31, indicating a potential upside of 99.95%. Given Evolus' higher possible upside, research analysts plainly believe Evolus is more favorable than Merus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolus	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Merus	0 Sell rating(s)	0 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	3.13

Do insiders & institutionals believe in EOLS or MRUS?

90.7% of Evolus shares are held by institutional investors. Comparatively, 96.1% of Merus shares are held by institutional investors. 6.1% of Evolus shares are held by company insiders. Comparatively, 4.6% of Merus shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has more risk & volatility, EOLS or MRUS?

Evolus has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Merus has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.

Does the media favor EOLS or MRUS?

In the previous week, Evolus had 10 more articles in the media than Merus. MarketBeat recorded 17 mentions for Evolus and 7 mentions for Merus. Merus' average media sentiment score of 0.98 beat Evolus' score of 0.10 indicating that Merus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evolus	3 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Merus	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better earnings & valuation, EOLS or MRUS?

Evolus has higher revenue and earnings than Merus. Evolus is trading at a lower price-to-earnings ratio than Merus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolus	$266.27M	2.57	-$61.69M	-$0.81	-13.31
Merus	$36.13M	81.58	-$154.94M	-$3.27	-13.05

Does the MarketBeat Community prefer EOLS or MRUS?

Merus received 1 more outperform votes than Evolus when rated by MarketBeat users. However, 73.13% of users gave Evolus an outperform vote while only 67.72% of users gave Merus an outperform vote.

Company	Underperform	Outperform
Evolus	Outperform Votes 362 73.13%	Underperform Votes 133 26.87%
Merus	Outperform Votes 363 67.72%	Underperform Votes 173 32.28%

Summary

Merus beats Evolus on 10 of the 19 factors compared between the two stocks.